Syndax Pharmaceuticals In...

NASDAQ: SNDX · Real-Time Price · USD
15.70
0.97 (6.59%)
At close: Aug 15, 2025, 1:21 PM

Syndax Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-318.76M -209.36M -149.34M 24.93M
Depreciation & Amortization
8K 12K 33K 43K
Stock-Based Compensation
43.03M 30.95M 16.02M 13.32M
Other Working Capital
23.21M 26.25M 2.98M -11.76M
Other Non-Cash Items
821K -14.06M -2.04M 187K
Deferred Income Tax
n/a n/a n/a 255K
Change in Working Capital
13.27M 31.86M 1.66M -9.6M
Operating Cash Flow
-274.9M -160.6M -133.68M 29.13M
Capital Expenditures
n/a n/a -225K -129K
Cash Acquisitions
n/a n/a 225K 40.74K
Purchase of Investments
-557.05M -354.61M -495.35M -294.72M
Sales Maturities Of Investments
337.28M 472.21M 308.93M 253.97M
Other Investing Acitivies
n/a n/a 225K -40.74K
Investing Cash Flow
-219.78M 117.61M -186.19M -40.87M
Debt Repayment
n/a n/a -21M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
353.37M 6.04M 11.86M 32.13M
Financial Cash Flow
353.37M 264.13M 172.25M 118.46M
Net Cash Flow
-141.31M 221.14M -147.61M 106.72M
Free Cash Flow
-274.9M -160.6M -133.9M 29M